NEWS
News Articles
Lt. Gov. Duncan names health-care task force
Lt. Gov. Geoff Duncan named a task force Wednesday that will look for ways to improve Georgians’ access to quality health care while reducing costs. Duncan will chair the 16-member panel, which will include members of the state Senate as well as health-care executives and academics specializing in medical subjects. As lieutenant governor, Duncan serves as president…
Read MorePiedmont Healthcare joins nonprofit generic drug company Civica
Piedmont Healthcare has joined Civica, a new nonprofit generic drug company with a goal of reducing chronic drug shortages in the United States, Piedmont announced Thursday. Launched last year, Civica supplies its members at least 14 drugs commonly used by hospitals in emergency care, surgery, pain management and in treating hypertension. More recently, Civica announced…
Read MoreAlimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema
Aug 5, 2019 Specialised Therapeutics, an Australian biopharmaceutical company and Alimera’s distribution partner, to next seek national reimbursement ATLANTA, Aug. 05, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces today that the Australian Therapeutic Goods Administration (TGA), the division of the Australian…
Read MoreArunA Bio Raises $13 Million in Common Stock Financing
— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio establishes an office in Research Triangle Park, NC — Athens, GA; Research Triangle Park, NC – July 24, 2019—ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,…
Read MoreFreenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection
Proceeds Will Fund Pivotal Validation Study of Company’s Blood-based Test for the Screening of Colorectal Cancer Platform Has Potential for Use in Multiple Cancer Types and Enhanced Drug Development by Characterizing Tumor and Immune Signatures July 24, 2019 09:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Freenome, a biotechnology company that has pioneered the most…
Read MoreCenExel Clinical Research Establishes Clinical Trial Centers Of Excellence Company
Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development SALT LAKE CITY, July 18, 2019 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of their Centers of Excellence company, which unites four of the most experienced clinical research units in the country to design…
Read More